Avanir Pharmaceuticals Gets $30M In Credit Facility
, the biopharmaceuticals firm focused on treatments for central nervous system disorders, has received $30M in a debt funding round, according to lenders Oxford FInance and Silicon Valley Bank. Avanir will use the funding to expand its product line and working capital. Terms of the debt financing were not announced.
posted on Friday, June 22, 2012
> Avanir Pharmaceuticals Names Research VP
> Avanir Pharmaceuticals Adds Director
> AVANIR Pharmaceuticals Sells Compound
> Ligand Pharmaceuticals Gets $10M In Credit Facility
> AVANIR Gets $40M In PIPE